Clinical Trial Update: Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)

View source ↗

Summary

This clinical trial update reports the completion of the San Antonio Heart Study evaluating diabetes mellitus type 2 and cardiovascular risk in Mexico City.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED